Carbenicillin Disodium

CHEMBL606260 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

422.4 g/mol

LogP

—

Phase

4

The disodium salt of carbenicillin, formulated for intravenous or intramuscular injection to treat serious infections caused by Pseudomonas and other susceptible gram-negative bacteria. Like carbenicillin, it disrupts bacterial cell wall construction. It has largely been superseded by newer extended-spectrum penicillins and other beta-lactam antibiotics.

Moleküler Ağırlık

422,4000 g/mol

TPSA

155,00 Å²

Etki Mekanizması

Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), preventing transpeptidation and cross-linking of peptidoglycan chains. This weakens the bacterial cell wall, leading to osmotic lysis and cell death.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mekanizma

Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), preventing transpeptidation and cross-linking of peptidoglycan chains. This weakens the bacterial cell wall, leading to osmotic lysis and cell …

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CC1(C)S[C@@H]2[C@H](NC(=O)C(C(=O)[O-])c3ccccc3)C(=O)N2[C@H]1C(=O)[O-].[Na+].[Na+]

InChI

InChI=1S/C17H18N2O6S.2Na/c1-17(2)11(16(24)25)19-13(21)10(14(19)26-17)18-12(20)9(15(22)23)8-6-4-3-5-7-8;;/h3-7,9-11,14H,1-2H3,(H,18,20)(H,22,23)(H,24,25);;/q;2*+1/p-2/t9?,10-,11+,14-;;/m1../s1

Molecular Formula

C17H16N2Na2O6S

HBD / HBA

1 / 7

Döndürülebilir Bağlar

3

Ağır Atomlar

28

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

The disodium salt of carbenicillin, formulated for intravenous or intramuscular injection to treat serious infections caused by Pseudomonas and other susceptible gram-negative bacteria. Like carbenicillin, it disrupts bacterial cell wall construction. It has largely been superseded by newer extended-spectrum penicillins and other beta-lactam antibiotics.

Inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), preventing transpeptidation and cross-linking of peptidoglycan chains. This weakens the bacterial cell wall, leading to osmotic lysis and cell death.

Yes, Carbenicillin Disodium is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL606260. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 20933. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Carbenicillin Disodium PillFYI'da

Yapı

Hızlı Veriler

Formül: C17H16N2Na2O6S

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.